106 related articles for article (PubMed ID: 15046703)
1. Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer.
Patierno SR; Manyak MJ; Fernandez PM; Baker A; Weeraratna AT; Chou DS; Szlyk G; Geib KS; Walsh C; Patteras J
Clin Prostate Cancer; 2002 Sep; 1(2):118-24. PubMed ID: 15046703
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin.
Antico G; Lingen MW; Sassano A; Melby J; Welch RW; Fiore S; Pilon AL; Miele L
J Cell Physiol; 2006 May; 207(2):553-61. PubMed ID: 16453303
[TBL] [Abstract][Full Text] [Related]
3. Loss of uteroglobin expression in prostate cancer: relationship to advancing grade.
Weeraratna AT; Cajigas JA; Schwartz A; Enquist EG; Manyak MJ; Patierno SR
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2295-300. PubMed ID: 9815627
[TBL] [Abstract][Full Text] [Related]
4. Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene.
Zhang Z; Kundu GC; Panda D; Mandal AK; Mantile-Selvaggi G; Peri A; Yuan CJ; Mukherjee AB
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3963-8. PubMed ID: 10097146
[TBL] [Abstract][Full Text] [Related]
5. Uteroglobin promoter-targeted c-MYC expression in transgenic mice cause hyperplasia of Clara cells and malignant transformation of T-lymphoblasts and tubular epithelial cells.
Geick A; Redecker P; Ehrhardt A; Klocke R; Paul D; Halter R
Transgenic Res; 2001 Dec; 10(6):501-11. PubMed ID: 11817538
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium.
Leyton J; Manyak MJ; Mukherjee AB; Miele L; Mantile G; Patierno SR
Cancer Res; 1994 Jul; 54(14):3696-9. PubMed ID: 8033085
[TBL] [Abstract][Full Text] [Related]
7. SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer.
Yuan D; Wang W; Su J; Zhang Y; Luan B; Rao H; Cheng T; Zhang W; Xiao S; Zhang M; Jiang FN; Sun Z; Jia Z; Zhong WD; Zhu J
Curr Cancer Drug Targets; 2018; 18(9):894-904. PubMed ID: 29295692
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
9. Uteroglobin binding proteins: regulation of cellular motility and invasion in normal and cancer cells.
Kundu GC; Zhang Z; Mantile-Selvaggi G; Mandal A; Yuan CJ; Mukherjee AB
Ann N Y Acad Sci; 2000; 923():234-48. PubMed ID: 11193760
[TBL] [Abstract][Full Text] [Related]
10. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-uteroglobin suppresses COX-2 expression via inhibition of NF-kappaB activity in lung cancer cells.
Yoon JM; Lim JJ; Yoo CG; Lee CT; Bang YJ; Han SK; Shim YS; Kim YW
Lung Cancer; 2005 May; 48(2):201-9. PubMed ID: 15829319
[TBL] [Abstract][Full Text] [Related]
12. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
Eastham JA; Grafton W; Martin CM; Williams BJ
J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of adenovirus-uteroglobin transduction on the growth of lung cancer cell lines.
Lee JC; Park KH; Han SJ; Yoo CG; Lee CT; Han SK; Shim YS; Kim YW
Cancer Gene Ther; 2003 Apr; 10(4):287-93. PubMed ID: 12679801
[TBL] [Abstract][Full Text] [Related]
14. The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice.
Sandmöller A; Halter R; Gómez-La-Hoz E; Gröne HJ; Suske G; Paul D; Beato M
Oncogene; 1994 Oct; 9(10):2805-15. PubMed ID: 8084586
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
16. The Drg-1 gene suppresses tumor metastasis in prostate cancer.
Bandyopadhyay S; Pai SK; Gross SC; Hirota S; Hosobe S; Miura K; Saito K; Commes T; Hayashi S; Watabe M; Watabe K
Cancer Res; 2003 Apr; 63(8):1731-6. PubMed ID: 12702552
[TBL] [Abstract][Full Text] [Related]
17. Reversion of human prostate tumorigenic growth by azatyrosine.
Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
[TBL] [Abstract][Full Text] [Related]
18. Uteroglobin: a novel cytokine?
Mukherjee AB; Kundu GC; Mantile-Selvaggi G; Yuan CJ; Mandal AK; Chattopadhyay S; Zheng F; Pattabiraman N; Zhang Z
Cell Mol Life Sci; 1999 May; 55(5):771-87. PubMed ID: 10379362
[TBL] [Abstract][Full Text] [Related]
19. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.
Kasper S; Smith JA
J Urol; 2004 Jul; 172(1):12-9. PubMed ID: 15201729
[TBL] [Abstract][Full Text] [Related]
20. Expression of the uteroglobin promoter in epithelial cell lines from endometrium.
Helftenbein G; Misseyanni A; Hagen G; Peter W; Slater EP; Wiehle RD; Suske G; Beato M
Ann N Y Acad Sci; 1991; 622():69-79. PubMed ID: 2064210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
